Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    migraine | Bristol-Myers [Lead]
Show Display Options
Rank Status Study
1 Completed Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition
Condition: Migraine
Intervention: Drug: BMS-927711 (CGRP Antagonist)
2 Completed Dose Ranging Study of a Drug for the Treatment of Acute Migraine
Condition: Migraine - Acute
Interventions: Drug: Placebo matching BMS-927711;   Drug: BMS-927711;   Drug: Sumatriptan

Indicates status has not been verified in more than two years